Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

A nanovector with complete discrimination for targeted delivery to Plasmodium falciparum-infected versus non-infected red blood cells in vitro.

Urbán P, Estelrich J, Cortés A, Fernàndez-Busquets X.

J Control Release. 2011 Apr 30;151(2):202-11. doi: 10.1016/j.jconrel.2011.01.001. Epub 2011 Jan 9.

PMID:
21223986
2.

Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy.

Moles E, Urbán P, Jiménez-Díaz MB, Viera-Morilla S, Angulo-Barturen I, Busquets MA, Fernàndez-Busquets X.

J Control Release. 2015 Jul 28;210:217-29. doi: 10.1016/j.jconrel.2015.05.284. Epub 2015 May 23.

PMID:
26008752
3.

Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells.

Marques J, Moles E, Urbán P, Prohens R, Busquets MA, Sevrin C, Grandfils C, Fernàndez-Busquets X.

Nanomedicine. 2014 Nov;10(8):1719-28. doi: 10.1016/j.nano.2014.06.002. Epub 2014 Jun 15.

PMID:
24941466
4.

Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs.

Movellan J, Urbán P, Moles E, de la Fuente JM, Sierra T, Serrano JL, Fernàndez-Busquets X.

Biomaterials. 2014 Sep;35(27):7940-50. doi: 10.1016/j.biomaterials.2014.05.061. Epub 2014 Jun 13.

PMID:
24930847
5.

Use of poly(amidoamine) drug conjugates for the delivery of antimalarials to Plasmodium.

Urbán P, Valle-Delgado JJ, Mauro N, Marques J, Manfredi A, Rottmann M, Ranucci E, Ferruti P, Fernàndez-Busquets X.

J Control Release. 2014 Mar 10;177:84-95. doi: 10.1016/j.jconrel.2013.12.032. Epub 2014 Jan 7.

PMID:
24412735
6.

Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors.

Urbán P, Estelrich J, Adeva A, Cortés A, Fernàndez-Busquets X.

Nanoscale Res Lett. 2011 Dec 7;6:620. doi: 10.1186/1556-276X-6-620.

7.

Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice.

Isacchi B, Bergonzi MC, Grazioso M, Righeschi C, Pietretti A, Severini C, Bilia AR.

Eur J Pharm Biopharm. 2012 Apr;80(3):528-34. doi: 10.1016/j.ejpb.2011.11.015. Epub 2011 Nov 28.

PMID:
22142592
8.

Down-regulation of tight junction mRNAs in human endothelial cells co-cultured with Plasmodium falciparum-infected erythrocytes.

Susomboon P, Maneerat Y, Dekumyoy P, Kalambaheti T, Iwagami M, Komaki-Yasuda K, Kawazu S, Tangpukdee N, Looareesuwan S, Kano S.

Parasitol Int. 2006 Jun;55(2):107-12. Epub 2006 Jan 4.

PMID:
16388977
9.

Stearylamine Liposomal Delivery of Monensin in Combination with Free Artemisinin Eliminates Blood Stages of Plasmodium falciparum in Culture and P. berghei Infection in Murine Malaria.

Rajendran V, Rohra S, Raza M, Hasan GM, Dutt S, Ghosh PC.

Antimicrob Agents Chemother. 2015 Dec 14;60(3):1304-18. doi: 10.1128/AAC.01796-15.

10.

Plasmodium falciparum-infected erythrocytes: a mutational analysis of cytoadherence via murine thrombomodulin.

Rabhi-Sabile S, Steiner-Mosonyi M, Pollefeyt S, Collen D, Pouvelle B, Gysin J, Boffa MC, Conway EM.

Thromb Haemost. 1999 May;81(5):815-21.

PMID:
10365758
11.

Host response to cytoadherence in Plasmodium falciparum.

Chakravorty SJ, Hughes KR, Craig AG.

Biochem Soc Trans. 2008 Apr;36(Pt 2):221-8. doi: 10.1042/BST0360221. Review.

PMID:
18363564
12.

Empowering malaria vaccination by drug administration.

Sauerwein RW, Bijker EM, Richie TL.

Curr Opin Immunol. 2010 Jun;22(3):367-73. doi: 10.1016/j.coi.2010.04.001. Epub 2010 Apr 29. Review.

PMID:
20434895
14.

In vitro assessment of the pharmacodynamic properties and the partitioning of OZ277/RBx-11160 in cultures of Plasmodium falciparum.

Maerki S, Brun R, Charman SA, Dorn A, Matile H, Wittlin S.

J Antimicrob Chemother. 2006 Jul;58(1):52-8. Epub 2006 May 30.

PMID:
16735432
15.
16.

Normal human erythrocytes express CD36, an adhesion molecule of monocytes, platelets, and endothelial cells.

van Schravendijk MR, Handunnetti SM, Barnwell JW, Howard RJ.

Blood. 1992 Oct 15;80(8):2105-14.

17.

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.

J Control Release. 2001 Jul 6;74(1-3):95-113.

PMID:
11489487
18.

Seasonal variation in agglutination of Plasmodium falciparum-infected erythrocytes.

Giha HA, Theander TG, Staalsø T, Roper C, Elhassan IM, Babiker H, Satti GM, Arnot DE, Hviid L.

Am J Trop Med Hyg. 1998 Apr;58(4):399-405.

PMID:
9574782
19.

Use of specific polyclonal antibodies for site specific drug targeting to malaria infected erythrocytes in vivo.

Singh AM, Owais M, Varshney GC.

Indian J Biochem Biophys. 1993 Dec;30(6):411-3.

PMID:
8005626

Supplemental Content

Support Center